Jan Basile, MD

September 5, 2018 // Randy Glick

Jan Basile, MD

Dr. Basile earned his medical degree from the Medical College of Virginia in Richmond. He then completed his internship and residency at the Medical University of South Carolina in Charleston, where he was also Chief Resident. He is board certified in internal medicine and is a Fellow of the American College of Physicians (FACP), the American Society of Hypertension (FASH), and the American Heart Association (FAHA). For many years he served on the American Society of Hypertension (ASH) Board of Directors, and with the recent dissolution of ASH, he is serving within the AHA as Vice-Chair of Clinical Programs on the Council of Hypertension.

His many honors and awards include the Medical University of South Carolina School of Medicine Excellence in Teaching award, the Golden Apple award, and, in 2014, he was the first recipient of the SC Department of Health and Environmental Control Hypertension Physician of the Year award. He was President of the Southern Medical Association from 2008-2009.      

Currently, he is Professor of Medicine at the Medical University of South Carolina (MUSC).  For the past 9 years he has volunteered at the Ralph H Johnson VA Medical Center. Prior to this, he spent 31 years at the VA while faculty at MUSC having retired as Chief of Primary Care in 2009.  He continues to direct the resistant hypertension clinic within the Seinsheimer Cardiovascular Health Program, a multi-risk factor lipid and resistant hypertension referral clinic at MUSC.                       

Dr. Basile’s research interests include outcome-based studies involving hypertension, lipid disorders, and diabetes. He has been involved in many large hypertension trials including the ALLHAT, ACCORD, ONTARGET, ACCOMPLISH, and SPRINT trials and most recently has concluded his participation in SPRINT-MIND, under the auspices of the National Heart, Lung, and Blood Institute. He was a contributing reviewer of the Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) and the 2017 ACC-AHA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults.

Dr. Basile has published more than 300 original papers, abstracts, and book chapters, as well as a textbook, Hot Topics: Hypertension. He also is a contributing author for the hypertension section of "Up To Date".

SMA/ASH Faculty for SMA’s 2018 Annual Meeting: Michael Wagner, MD, FACP, RDMS

September 5, 2018 // Randy Glick
Register

Michael Wagner, MD, FACP, RDMS

Michael Wagner, MD, FACP, RDMS, is an Assistant Professor of Medicine at the University of South Carolina School of Medicine Greenville in South Carolina. There he serves as the Director of Internal Medicine Ultrasound for Greenville Health Systems, helping to build point-of-care ultrasound curricula across the undergraduate, graduate and continuing medical education spectrum.  His research interests include bedside medicine and physical diagnosis, lung ultrasound, and medical simulation. Recently he served as guest editor for the July 2018 special issue on point-of-care ultrasound in the Southern Medical Journal.

SMA/ASH Faculty for SMA’s 2018 Annual Meeting: John D. Bisognano, MD, PhD

September 5, 2018 // Randy Glick
Register

John D. Bisognano, MD, PhD

Dr. Bisognano is a Professor of Medicine and Director of Outpatient Services in the Division of Cardiology at the University of Rochester Medical Center where he joined the faculty in 2001. His research areas of interest include approaches to treatment of patients with resistant and refractory hypertension, including clinical trials testing new medical devices. He is also engaged in community-wide efforts at blood pressure reduction as well as NIH funded in investigating novel methods for treatment of patients with Stage I hypertension. Dr. Bisognano is a frequent lecturer on hypertension guidelines, treatment approaches, and clinical research both locally as well as internationally.

He received bachelor's degrees in biology and political science from MIT and MD from Upstate Medical Center in Syracuse.  He also obtained a PhD in Physical Chemistry from SUNY-Binghamton and completed a medical residency at the University of Michigan Hospitals. Dr. Bisognano completed fellowships in hypertension at the University of Michigan as well as in Cardiology at the University of Colorado, with a specialty in advanced heart failure and transplantation.

 

SMA/ASH Faculty for SMA’s 2018 Annual Meeting: Eric A. Brown, MD, FACEP

September 5, 2018 // Randy Glick
Register

Eric A. Brown, MD, FACEP

Dr. Eric A. Brown has served as the System VP for Patient Flow & Care Innovation for Palmetto Health in Columbia SC since August of 2016.  In this capacity he has led the construction of a comprehensive flow improvement strategy for this 4 hospital system by chartering a dedicated team, reengineering countless processes to improve efficiencies across the organization, and optimizing health IT systems, including TeleTracking, to create a data-driven enterprise.  Additionally, Dr. Brown has served as the Physician Executive (CMO) at Palmetto Health Richland, the flagship academic hospital of the Palmetto Health system, since February of 2014.

 Prior to that time, he served as the Executive Director of the Palmetto Health – University of South Carolina School of Medicine Simulation Center from its inception in 2006.  He has held a number of leadership roles in the simulation arena including Chair of the Public Affairs and Government Relations Committee for the Society for Simulation in Healthcare and a member of the Board of Directors. Dr. Brown also served on the Board of Directors for the Advanced Initiatives in Medical Simulation (AIMS) for 5 years, an organization dedicated to simulation advocacy on a federal, state, and local level. He has regularly visited South Carolina legislators on Capitol Hill to discuss the benefits of simulation and support for pending legislation to advance this cause.
He is a board certified Emergency Medicine physician, faculty member with the Palmetto Health Emergency Medicine Residency Program, and Fellow of the American College of Emergency Physicians.

 Dr. Brown completed his baccalaureate at Duke University in 1990. He was a Territory Manager for Baxter Healthcare Corporation before pursuing his graduate degree. He entered medical school in 1996 at Boston University School of Medicine, where he was inducted as a member of the Alpha Omega Alpha Medical Honor Society in 2000. He completed his residency in Emergency Medicine in 2003 at Palmetto Health Richland in Columbia, South Carolina.

SMA/ASH Faculty for SMA’s 2018 Annual Meeting: Rachel Brown, MD

September 5, 2018 // Randy Glick
Register

Rachel Brown, MD

Dr. Rachel Brown is a family physician certified by the American Academy of Family Physicians. She received her MD from Boston University School of Medicine in 2000 and completed her residency training at the Palmetto Health Family Medicine Residency Program in 2003, followed by a Faculty Development fellowship at University of North Carolina Chapel Hill. Dr. Brown is experienced in the medical care of children and adolescents, young and middle-aged adults, pregnant women, and the elderly. Her special interests are in prevention and health maintenance, chronic disease management, sports medicine, and wellness coaching with goal-setting.

 Dr. Brown worked as the predoctoral director and associate residency program director at the Palmetto Health Family Medicine Residency for twelve years.  After working on special wellness projects for Palmetto Health team members as a wellness consultant, she was hired by Palmetto Health as the Medical Director of Health and Wellness.  She provides medical oversight of and administrative consultation on the development of team member wellness programs and has a special interest in physician and provider resilience interventions.

 She is also the owner of Free To Move Fitness, LLC, a family fitness company that provides health education, fitness classes, and wellness coaching to adults and children, especially those with or at risk for chronic disease.  Dr. Brown is certified as an American Council on Exercise Group Fitness Instructor and an International Youth Conditioning Association Youth Fitness Specialist.

SMA/ASH Faculty for SMA’s 2018 Annual Meeting: Charlee Alexander, BA, MPH

September 5, 2018 // Randy Glick
Register

Charlee Alexander, BA, MPH

Charlee Alexander is a Program Officer at the National Academy of Medicine (NAM) where she directs the Action Collaborative on Clinician Well-being and Resilience, a network of more than 150 organizations committed to reversing trends in clinician burnout and improving the well-being of health care professionals. She also co-directs the NAM Culture of Health Program, a multiyear collaborative effort funded by the Robert Wood Johnson Foundation to identify strategies to create and sustain conditions that support equitable good health for all Americans. Charlee graduated from the University of Chicago with a bachelor’s degree in political science and is currently pursuing a Master’s degree in public health at the Johns Hopkins Bloomberg School of Public Health.

SMA/ASH Faculty for SMA’s 2018 Annual Meeting: March E. Seabrook, MD, FACG

September 5, 2018 // Randy Glick
Register

March E. Seabrook, MD, FACG

March Seabrook, MD, FACG has been practicing gastroenterology in his home state of South Carolina since 1991.  He grew up in Anderson and is a graduate of Wofford College and the University of South Carolina School of Medicine.  He quickly developed a passion for colorectal cancer prevention after two of his best friends fathers died of this disease.  He has channeled much of his professional energy into advancing screening programs for the uninsured in the state. These efforts have been recognized with multiple local, state and national awards.  Consultants in Gastroenterology is a private independent practice with nine physicians in central South Carolina.

 In addition, he has served in numerous leadership positions including founder and first President of the South Carolina Gastroenterology Association and is currently the President of the South Carolina Medical Association.

SMA/ASH Faculty for SMA’s 2018 Annual Meeting: Marc G. Jaffe, MD

September 5, 2018 // Randy Glick
Register

Marc G. Jaffe, MD

Dr. Jaffe is the Senior Vice President of the Resolve to Save 100 Million Lives Cardiovascular Health Initiative, an initiative of Vital Strategies, and a Senior Physician of the Permanente Medical Group in South San Francisco, California.

 Dr. Jaffe joined Kaiser Permanente in 1993, and in 2000 he led the establishment of the Kaiser Permanente Northern California Hypertension Program. In 2004 he led the creation of the Kaiser Permanente Northern California Prevent Heart Attacks and Strokes Everyday (PHASE) program which designs, implements, and evaluates the delivery of cardiovascular preventive services to high risk individuals with diabetes or cardiovascular disease.

 From 2009 to 2017 he was the Clinical Leader of the Kaiser National Integrated Cardiovascular Health Guideline Team.  From 2013-2015 he served as a consultant to the Centers for Disease Control (CDC) for the Global Standardization Treatment Project and from 2015 - 2017 he was a technical advisor for the World Health Organization/PanAmerican Health Organization Hypertension Program. In September 2017, he joined Resolve to Save Lives to Save Lives as the Senior Vice President of Cardiovascular Health, with the goal of preventing 100 million deaths from cardiovascular disease in low and middle-income countries.

 Dr. Jaffe attended the University of California at Berkeley and the Baylor College of Medicine in Houston, Texas.  He completed residency at the University of California, San Diego, and did his Endocrinology fellowship at the University of California, San Francisco. He is an Associate Clinical Professor of Medicine at the University of California, San Francisco, Medical School. He is board certified in Internal Medicine and in Diabetes, Endocrinology, and Metabolism.

SMA/ASH Faculty for SMA’s 2018 Annual Meeting: Jerry R. Youkey, MD

September 5, 2018 // Randy Glick
Register

Jerry R. Youkey, MD

Jerry R. Youkey, MD, GHS Executive Vice President and Chief Academic Officer, Founding Dean of the University of South Carolina School of Medicine Greenville and USC Associate Provost for Health Sciences - Greenville, joined Greenville Health System (GHS) in 1998. Dr. Youkey is responsible for the health system’s research and education activities and for the growing University of South Carolina health sciences presence in the Upstate.

Prior to joining GHS, Dr. Youkey served as chief of the department of surgery and director of the peripheral vascular fellowship program at Geisinger Medical Center in Danville, Pennsylvania. He also served in the United States Army Medical Corps and was honorably discharged in 1984 with the rank of lieutenant colonel.

Dr. Youkey is certified by the American Board of Surgery in general vascular surgery. He is a member of several professional societies and has authored numerous books, abstracts and journal articles. He holds the academic appointment of professor and dean at the University of South Carolina School of Medicine Greenville.

Dr. Youkey earned a bachelor’s degree in biology from Stanford University and a medical degree from the Medical College of Wisconsin. He served a rotating internship and general surgery residency at William Beaumont Army Medical Center in El Paso, Texas, and a fellowship in peripheral vascular surgery at Walter Reed Army Medical Center in Washington, DC.

SMA/ASH Faculty for SMA’s 2018 Annual Meeting: Les W. Hall, MD

September 5, 2018 // Randy Glick
Register

Les W. Hall, MD

Les W. Hall, MD, is a professor of medicine and executive dean of the University of South Carolina School of Medicine in Columbia. He also serves as the chief executive officer of the Palmetto Health-USC Medical Group, the largest and most comprehensive group of health care providers in central South Carolina.

 Prior to moving to South Carolina in early 2015, Dr. Hall served in a variety of roles at the University of Missouri School of Medicine in Columbia, including chief medical officer and interim dean of the School of Medicine. Dr. Hall received his medical degree from Washington University in St. Louis and completed training in internal medicine at the National Naval Medical Center in Bethesda, Maryland. He continues to practice as an internal medicine hospital-based physician.

 Dr. Hall’s academic work has focused on advancing interprofessional education, especially in the areas of quality improvement, patient safety and teamwork.

SMA/ASH Faculty for SMA’s 2018 Annual Meeting: Mark Williams, MD, MBA, JD

September 5, 2018 // Randy Glick
Register

Mark Williams, MD, MBA, JD

Dr. Mark Williams is currently the Chief Clinical and Academic Officer for the Palmetto Health System in Columbia, South Carolina.  Dr. Mark Williams was the Chief Physician Executive for Tenet’s Brookwood Baptist System in Birmingham, Alabama from 2014 to 2017. He is a past president of the Southern Medical Association and from 2008 to 2014 he served as the Chief Medical Officer of the North Mississippi Health System in Tupelo, Mississippi – the largest rural health care system in the United States and the recipient of the 2012 National Malcolm Baldrige Award for Organizational Performance.

He is a 1980 graduate of the University of South Alabama College of Medicine and, after an internship in general surgery and a residency year in internal medicine, he completed his post-graduate training in anesthesiology.  He was the chief resident in anesthesiology and completed all of his postgraduate training at the University of Alabama in Birmingham. Dr. Williams joined the UAB Department of Anesthesiology after his training and practiced anesthesia at Carraway Methodist Medical Center, a 617-bed Level I Trauma and teaching hospital for over 20 years.

He is a former board chairman of the Alabama Quality Assurance Foundation and from 2006 to 2008 he was the Chief Medical Officer for the St. Vincent’s system in Birmingham, Alabama and chairman of Ascension Health’s Physician Informatics Committee and the Task Force on Disclosure of Unanticipated Outcomes. Dr. Williams is a 2001 graduate of the Alabama School of Law and a member of the Alabama State Bar. He completed the MBA program at Samford University in 1995 and is a former medical director for Alabama Power Company.

SMA/ASH Faculty for SMA’s 2018 Annual Meeting: David M. Joyner, MD

September 5, 2018 // Randy Glick
Register

David M. Joyner, MD

David M. Joyner, MD, serves as senior vice president and executive director of the Andrews Institute. Dr. Joyner is responsible for the day-to-day operations of the Andrews Institute, including physician alignment, strategic business partnerships, and affiliations and recruitment.

 Dr. Joyner is a board-certified orthopaedic surgeon with a sports medicine emphasis. He is a former chairman and senior member of the United States Olympic Committee’s sports medicine team, and, most recently, he was the athletic director for the Pennsylvania State University. He is also a former member of Penn State’s Board of Trustees. While a student at Penn State, he was a team captain of the football and wrestling teams, an All-American in both sports, as well as an Academic All-American.
 Dr. Joyner earned his medical degree from Penn State’s College of Medicine and served residencies in general and orthopaedic surgery at the university’s Milton S. Hershey Medical Center.

SMA/ASH Faculty for SMA’s 2018 Annual Meeting: Norman R.C. Campbell, CM, BHSc, FCAHS, MD, FRCPC

September 5, 2018 // Randy Glick
Register

Norman R.C. Campbell, CM, BHSc, FCAHS, MD, FRCPC

Dr. Campbell is a General Internist, a Professor of Medicine, Community Health Sciences and Physiology and Pharmacology and a member of the Libin Cardiovascular Institute of Alberta and O’Brien Institute of Public Health at the University of Calgary.

Dr. Campbell is currently the Executive member (Immediate Past President) of the World Hypertension League (Sept 2015-2019); a member of the Pan American Health Organization/World Health Organization Technical Advisory Group on Cardiovascular Disease Prevention through Dietary Salt Reduction (2015-); a member of the World Health Organization (WHO) Expert Advisory Panel on Nutrition; and Consultant to RESOLVE (to save 100 million lives), to the Task Force for Global Health, and to several national governmental programs to reduce dietary salt and to control hypertension.

Dr. Campbell has 450 publications in peer-reviewed journals, over 450 national/ international invited presentations and has received several recognitions for his efforts including the Order of Canada (2014).

SMA/ASH Faculty for SMA’s 2018 Annual Meeting: William Cushman, MD

September 5, 2018 // Randy Glick
Register

William C. Cushman, MD

Dr. William Cushman is Chief of the Preventive Medicine Section at the Veterans Affairs (VA) Medical Center and Professor of Preventive Medicine, Medicine, and Physiology at the University of Tennessee Health Science Center in Memphis, Tennessee.  Dr. Cushman graduated from the University of Mississippi School of Medicine in 1974, where he completed his residency training in 1977. He served on the faculty at the University of Mississippi and was on the staff at the VA, both in Jackson, MS, from 1977-1988, when he moved to the University of Tennessee and VA in Memphis, TN.

He was a member of the 2004 and the VA champion for the 2014 VA-Department of Defense Hypertension Clinical Practice Guideline committees, and was on the JNC 7 and JNC 8 U.S. hypertension guideline committees.  Dr. Cushman has been an investigator and on the leadership for many clinical trials in hypertension, diabetes, and lipid therapy, including a number of VA Cooperative Studies, and the NHLBI trials ALLHAT, ACCORD, and SPRINT.  He is currently co-chair of the Diuretic Comparison Project, a VA Cooperative Study, which compares the effect of the thiazide-type diuretics chlorthalidone and hydrochlorothiazide on major cardiovascular outcomes.

Dr. Cushman has received more than $60 million in research grant funding, has more than 285 journal article and book chapter publications, and has received several awards, including the 2010 Barnwell Award, the VA Clinical Science Research and Development’s highest honor for clinical science achievement, the 2017 Inter-American Society of Hypertension Lifetime Achievement Award, and the 2018 American Heart Association’s Council on Hypertension Irvine Page-Alva Bradley Lifetime Achievement Award.

SMA/ASH Faculty for SMA’s 2018 Annual Meeting: Robert M. Carey, MD, MACP

September 5, 2018 // Randy Glick
Register

Robert M. Carey, MD, MACP

Dr. Robert M. Carey is Dean, Emeritus, and Professor of Medicine at the University of Virginia School of Medicine. He is a world renowned cardiovascular endocrinologist and hypertension specialist. His research on hormonal control of blood pressure (BP) and hypertension has resulted in over 400 publications.

He has received numerous awards, including the American Heart Association (AHA) Lifetime Achievement Award and Excellence Award for Hypertension Research (Novartis Award) and the Thomas Jefferson Award (highest honor of the University of Virginia) for transforming medicine during his 16-year deanship.

Dr. Carey has been President of the AHA (Virginia Affiliate), the Endocrine Society, and the American Clinical and Climatological Association. He has chaired the AHA Hypertension Council, Council Operations Committee and Scientific Publishing Committee, co-chaired the 2017 AHA/American College of Cardiology Hypertension Guideline Writing Committee and chaired the 2018 AHA Scientific Statement on Resistant Hypertension Writing Committee. He is a Master of the American College of Physicians and an elected member of the American Society for Clinical Investigation, the Association of American Physicians and the National Academy of Medicine

SMA/ASH Faculty for SMA’s 2018 Annual Meeting: Brent M. Egan, MD

September 5, 2018 // Randy Glick
Register

Brent M. Egan, MD

Brent M. Egan, MD is Professor of Medicine at the University of South Carolina School of Medicine, Greenville and serves as the Vice-President, Research in the Care Coordination Institute.  He received his medical degree and training in medicine and hypertension at the University of Michigan. His research interests have centered on population health around metabolic syndrome, mechanisms of obesity-associated hypertension and vascular disease, and medical and social determinant drivers of cardiometabolic outcomes in populations. The work led to more than 300 original papers and reviews, positions on 7 editorial boards, and selection on the Best Doctors list for 1998–2013.  

Dr. Egan started the Outpatient Quality Improvement Network (OQUIN) Hypertension Initiative at the Medical University of South Carolina in 1999 to collaborate with primary care physicians in South Carolina and beyond to optimize control of modifiable cardiovascular risk factors, reduce cardiovascular morbidity and mortality, and improve health equity.  OQUIN transitioned to the Care Coordination Institute (CCI) in Greenville, South Carolina and is presently collaborating with ~1100 practices sites with more than 2.5 million patients. Many of these practices met 2017 standards of the Centers for Disease Control’s Million Hearts Program and 122 sites were recently recognized by the AHA/AMA Target:BP Program for BP control >70%.  

Dr. Egan’s current professional efforts center on improving cardiometabolic health and health equity and the care of adults with multiple chronic conditions. He remains committed to working with a broad range of colleagues translate the evidence-base into better population health.

SMA/ASH Faculty for SMA’s 2018 Annual Meeting: Raymond R. Townsend, MD

September 5, 2018 // Randy Glick
Register

Raymond R. Townsend, MD

Raymond R. Townsend, MD, is a Professor of Medicine and an Associate Director of the Clinical and Translational Research Center at the University of Pennsylvania.  He is currently a Principal Investigator on a 7-center U01 grant (DK-060984) studying factors in the progression of chronic kidney disease and the development and progression of cardiovascular disease in patients with CKD.  His formal certifications are in internal medicine (ABIM), nephrology (ABIM), clinical pharmacology (ASCP) and hypertension (ASH).

Dr. Townsend is a fellow in the American Heart Association and the Council for High Blood Pressure Research.  Research interests include role of vascular dynamics in CKD progression and the incidence/development of CVD in CKD. He was an empanelled member of JNC 8, and the co-chair of the 8th AHA Hypertension Summer School and an Investigator in SPRINT.  He was also the AHA Physician of the Year awardee for 2016.

 

SMA/ASH Faculty for SMA’s 2018 Annual Meeting: Carlos M. Ferrario, MD

September 5, 2018 // Randy Glick
Register

Carlos M. Ferrario, MD

Carlos M. Ferrario, MD, is a cardiologist whose research has advanced understanding and treatment of high blood pressure and vascular disease. A graduate of the University of Buenos Aires Medical School in 1963, Dr. Ferrario pursued postgraduate training in cardiology at the University of Goteborg and the Karolinska Institute in Sweden between 1964 and 1966 and then joined Dr. Irvine H. Page, a pioneer in hypertension research, at The Cleveland Clinic Foundation in 1966. Dr. Ferrario developed a premier program on the neural and endocrine causes of hypertension chairing the Department of Brain and Vascular Research of the Cleveland Clinic Foundation from 1984 to 1992. He founded the Hypertension and Vascular Research Center at the Wake Forest University School of Medicine in 1992, serving as its Director until 2009.

Dr. Ferrario’s research identified the mechanisms of action of angiotensin in the brain through his discovery of the area postrema as a site for the action of the hormone, the role of the heart in the development of arterial hypertension, and discovered new endocrine pathways leading to the formation and action of angiotensin peptides. Pioneering research in the renin-angiotensin system includes the discovery of the antihypertensive function of angiotensin, the role of angiotensin converting enzyme 2 as a component of the opposing arm of the renin angiotensin system, and the furthering of understanding as to how inhibitors of angiotensin converting enzyme and angiotensin receptor antagonists act on the body’s nervous and endocrine mechanisms to regulate blood pressure. His studies on the role of angiotensin II in the pathogenesis of atherosclerosis lead to increased recognition on the interaction between lipids and endocrine hormones in the evolution of atherosclerosis. The newer studies identifying the function of angiotensin as a novel tissue substrate forming angiotensin II directly by chymase rather than angiotensin converting enzyme are underscoring the important of species differences in characterizing the mechanisms accounting for the pathogenesis of heart and vascular disease.

Dr. Ferrario has published over 500 papers, 74 book chapters, and 5 books. He has mentored over 61 physicians, many of which have become major medical leaders in the USA, Japan, and Latin America. He is a former Established Investigator and the recipient of the Harry Goldblatt Award from the American Heart Association. In 1998, he was presented with the Ignacio Chaves Centennial Gold Medal of Honor by the National University of Mexico, an internationally recognized veneration of excellence in Cardiology and research. The European Society of Hypertension awarded Dr. Ferrario the 1999 Hypertension Angiotensin II Investigator of the Year. He was recognized and selected as the 1999 recipient of the Wake Forest University School of Medicine Established Investigator in Clinical Science award. In addition, he was awarded the Robert Tigersted award from the American Society of Hypertension and the Lifetime Achievement Award from the Inter-American Society of Hypertension for his contributions to the field of hypertension research in 2001. Additional awards include the Corcoran Award from the AHA in 2007, and the R Tigersted and J Wright awards from the Finnish (2008) and Australian (2008) Societies of Hypertension, respectively. In 2009, he received the Novartis Award for Hypertension Research from the Council of High Blood Pressure Research, American Heart Association, the highest recognition of achievements awarded by any organization in the world.

Dr. Ferrario is a member and officer of numerous medical organizations including membership in the American Physiological Society since 1967, Immediate Past-President of the Inter- American Society of Hypertension, Fellow of the American College of Cardiology, the Council for High Blood Pressure Research, the American Society of Hypertension, and the Southern Society for Clinical Investigation. Honorary memberships include Societies of Cardiology in Argentina, Brazil, Ecuador, Venezuela, Spain, and Mexico. Currently, he is the Founder and Immediate Past-Editor-in-Chief of Therapeutic Advances in Cardiovascular Disease and a Member of the Editorial Board of several journals.

Dr. Ferrario is the Founder of the Consortium for Southeastern Hypertension Control (COSEHC™), an organization which has pioneered medical and educational efforts directed to reduce cardiovascular deaths in the South, serving as its President and Chief Executive Officer until 2008.

 

SMA/ASH Faculty for SMA’s 2018 Annual Meeting: Michael A. Weber, MD, PhD

September 5, 2018 // Randy Glick
Register

Michael A. Weber, MD, PhD

Dr. Michael Weber is a Professor of Medicine at Downstate College of Medicine of the State University of New York. He received his medical degree from Sydney University in Australia.   

His career has focused largely on hypertension and preventive cardiology. He has been a leading part of several of the clinical trials that have helped define strategies for optimizing cardiovascular protection for patients with hypertension. He has also been very much involved with new drug development going back to the beta blockers and through to the contemporary angiotensin receptor blockers.

Dr. Weber is an author of over 500 articles in the peer-reviewed literature and has authored or edited 16 books.  He was a founder of the American Society of Hypertension (ASH) and the ASH Hypertension Clinical Specialists Accreditation Program and has served as President of both those organizations.  Dr. Weber maintains a strong interest in global hypertension issues and is a member of the Executive Committee of the International Society of Hypertension. He was Chair of the Writing Committee of the 2014 ASH/ISH Hypertension Clinical Practice Guidelines

He is currently Editor-in-Chief of the Journal of Clinical Hypertension, the official Journal of the World Hypertension League.  He is a Fellow of The American College of Physicians, The American College of Cardiology and The American Heart Association.  He has served on the Cardiovascular and Renal Drugs Advisory Board of the Food and Drug Administration and continues as a consultant to that Agency.  He has also served as Chairman of the Formulary Committee of a major pharmacy benefits provider serving many of the leading health plans in the United States.

His main research interests are in clinical trials of patients at high risk of cardiovascular events or strokes.  He is also participating actively in trials in patients with metabolic disorders such as diabetes and kidney disease.   Dr. Weber currently serves on the Steering Committees of several national and international clinical outcomes trials.

SMA/ASH Faculty for SMA’s 2018 Annual Meeting: John D. Bisognano, MD, PhD

September 5, 2018 // Randy Glick
Register

John D. Bisognano, MD, PhD

Dr. Bisognano is a Professor of Medicine and Director of Outpatient Services in the Division of Cardiology at the University of Rochester Medical Center where he joined the faculty in 2001. His research areas of interest include approaches to treatment of patients with resistant and refractory hypertension, including clinical trials testing new medical devices. He is also engaged in community-wide efforts at blood pressure reduction as well as NIH funded in investigating novel methods for treatment of patients with Stage I hypertension. Dr. Bisognano is a frequent lecturer on hypertension guidelines, treatment approaches, and clinical research both locally as well as internationally.

He received bachelor's degrees in biology and political science from MIT and MD from Upstate Medical Center in Syracuse.  He also obtained a PhD in Physical Chemistry from SUNY-Binghamton and completed a medical residency at the University of Michigan Hospitals. Dr. Bisognano completed fellowships in hypertension at the University of Michigan as well as in Cardiology at the University of Colorado, with a specialty in advanced heart failure and transplantation.

Dr. Bisognano has received numerous teaching awards, the Medical Center Board Award for Excellence in Clinical Care, as has served as past President of the New York State Chapter of the American College of Cardiology and Rochester Regional American Heart Association. He is President of the American Society of Hypertension and Vice-Chair of the AHA High Blood Pressure Council. Dr. Bisognano has over 105 peer-reviewed articles and has published two books in the area of heart failure and outpatient cardiology.

SMA Menu